Monopar Therapeutics MNPR Other operating expenses
Other operating expenses at other companies
Other financials
Where this comes from
Reported directly by Monopar Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Monopar Therapeutics’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Monopar Therapeutics's other operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Monopar Therapeutics's other operating expenses?
- Monopar Therapeutics (MNPR) reported other operating expenses of $5.23M in Q1 2026.
- How has Monopar Therapeutics's other operating expenses changed year-over-year?
- Monopar Therapeutics's other operating expenses increased by 62.2% year-over-year, from $3.22M to $5.23M.
- What is the long-term trend for Monopar Therapeutics's other operating expenses?
- Over 4 years (2021 to 2025), Monopar Therapeutics's other operating expenses has grown at a 16.3% compound annual growth rate (CAGR), from $9.13M to $16.7M.
- What does other operating expenses mean?
- Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.